Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Gene Expression Profiles Predict Infliximab Treatment Response in Patients with Treatment-Resistant Depression


ABSTRACT: To further explore predictors and targets of response to infliximab, differential gene expression was examined at baseline and after 6 and 24 hours and 2 weeks after the first infusion of infliximab in TRD patients who were infliximab responders versus nonresponders, and compared to placebo-treated patients. In a recent clinical trial, the TNF antagonist infliximab was found to reduce depressive symptoms compared to placebo but only in patients with increased inflammation as reflected by a CRP >5 mg/L. To further explore predictors and targets of response to infliximab, differential gene expression was examined at baseline and after 6 and 24 hours and 2 weeks after the first infusion of infliximab in TRD patients who were infliximab responders versus nonresponders, and compared to placebo-treated patients.

ORGANISM(S): Homo sapiens

SUBMITTER: Divya Mehta 

PROVIDER: E-GEOD-45468 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2012-11-03 | E-GEOD-42002 | biostudies-arrayexpress
2023-09-26 | PXD043982 | Pride
2024-08-22 | PXD052504 | Pride
2013-04-06 | E-GEOD-45821 | biostudies-arrayexpress
2013-04-15 | E-GEOD-42139 | biostudies-arrayexpress
2011-09-30 | E-GEOD-31969 | biostudies-arrayexpress
2013-03-29 | E-GEOD-45603 | biostudies-arrayexpress
2012-01-15 | E-GEOD-34039 | biostudies-arrayexpress
2014-08-31 | E-GEOD-60748 | biostudies-arrayexpress
2013-09-01 | E-GEOD-44815 | biostudies-arrayexpress